Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-03-02 | 2022-02-28 | KPTI | Shacham Sharon | CSO | A - Grant | $0.00 | +21.0K | 720.0K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Shacham Sharon | CSO | S - Sale | $10.24 | -6,226 | 898.1K | -0.7% | -$63.8K |
| DI | 2022-03-02 | 2022-02-28 | KPTI | Shacham Sharon | CSO | S - Sale | $10.24 | -6,226 | 713.8K | -0.9% | -$63.8K |
| DI | 2022-03-02 | 2022-02-28 | KPTI | Shacham Sharon | CSO | A - Grant | $0.00 | +27.0K | 27.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | A | A | 21,000 | $0.00 | 719,983 | I By Spouse | — | — | (F3) Represents the award of restricted stock units ("RSUs") to the spouse of the reporting person pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 28, 2023. |
| 2 | Common | Common Stock | 2022-02-28 | S | D | 6,226 | $10.24 | 898,131 | D By Spouse | — | — | (F1) This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.24 to $10.35, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-02-28 | S | D | 6,226 | $10.24 | 713,757 | I | — | — | (F4) This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person. (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.24 to $10.35, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (right to buy) | 2022-02-28 | A | A | 27,000 | $0.00 | 27,000 | I By Spouse | $10.33 · — to 2032-02-27 | 27,000 Common Stock | (F5) This option was granted to the spouse of the reporting person on February 28, 2022 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter. |